SCHEMBL524697

SCHEMBL524697

C=C(C)C1(O)CC=C(C)CC1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29209964 1.00 LMNA (0.36) LMNA
SCHEMBL29209906 1.00 LMNA (0.36) LMNA
SCHEMBL28695558 0.80 GLI1 (0.31)
SCHEMBL10908305 0.74
SCHEMBL3019783 0.71 LMNA (0.33) LMNA
SCHEMBL11807985 0.70 LMNA (0.50) LMNA
SCHEMBL11807991 0.70 LMNA (0.50) LMNA
SCHEMBL4837023 0.69
SCHEMBL9222798 0.68 LMNA (0.38) LMNA
Acetic Acid SCHEMBL16099584 0.68 GLI1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 381 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250283119-A1 FERMENTATION PROCESSES AND SYSTEMS MANUS BIO INC (US) 2025-09-11 US claimed
US-20250248400-A1 NANOPARTICULATE FORMULATION FOR PREVENTING OR TREATING CALLOSE FORMATION IN PLANTS PURDUE RESEARCH FOUNDATION (US) 2025-08-07 US claimed
US-20250034491-A1 MOSCATO WINE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS AVA FOOD LABS INC (US) 2025-01-30 US claimed
EP-4096618-B1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2025-01-29 EP claimed
US-20250008978-A1 COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS Voyage Foods, Inc. 2025-01-09 US claimed
EP-4470389-A2 COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS Voyage Foods, Inc. (US) 2024-12-04 EP claimed
CN-118788340-A Catalyst for synthesizing limonene-4-alcohol and application thereof 南平青华科技有限公司 2024-10-18 CN claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 EP claimed
EP-3930472-B1 COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2024-09-11 EP claimed
US-20240260600-A1 COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS Voyage Foods, Inc. 2024-08-08 US claimed
EP-1697386-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES General Electric Company A Corporation of the State of New York (US) 2006-09-06 EP claimed
WO-2005066187-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GENERAL ELECTRIC COMPANY (US) 2005-07-21 WO claimed
WO-2005066186-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS GENERAL ELECTRIC COMPANY (US) 2005-07-21 WO claimed
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed
US-20050136021-A1 Active-releasing cyclic siloxanes MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed
WO-2002051453-A1 FRAGRANCE COMPOSITIONS FOR CLOTH TRIMMED AND LEATHER TRIMMED CAR SCENTS ELSON PAUL (AU) 2002-07-04 WO claimed
EP-0659721-B1 Method for the photooxidation of terpene olefins HAARMANN & REIMER GMBH (DE) 1998-06-10 EP claimed
US-5620569-A Process for the photooxidation of terpene olefins HAARMANN & REIMER GMBH (DE) 1997-04-15 US claimed
EP-0100935-B1 SPIROLACTONES, THEIR USE AS PERFUMES, PERFUME COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION FIRMENICH SA (CH) 1986-02-26 EP claimed
EP-0100935-A1 Spirolactones, their use as perfumes, perfume compositions containing them and process for their preparation FIRMENICH SA (CH) 1984-02-22 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients F9, RPL39, ECPAS LMNA 568/4885
US-20050136021-A1 Active-releasing cyclic siloxanes F9, RPL39, ALDH16A1 LMNA 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.